EDC-MASLD is an EU-funded project focused on exploring the role of Endocrine-Disrupting Chemicals (EDCs) in the progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). With MASLD affecting 25% of the general population, it’s crucial to understand all contributing factors for effective prevention and intervention.
The EDC-MASLD consortium compirses 14 Partners from 9 countries that have diverse and complementary expertise in the domains of hepatology, endocrinology, toxicology, exposome research, metabolomics, systems biology, environmental economics, and communications & technology research, with respective PIs being global leaders in their fields.
